Showing results (71-80 of 80) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
British Journal of Cancer|January 10, 2008
Detection of GD2-positive cells in bone marrow samples and survival of patients with localised neuroblastomaM V Corrias, S Parodi, R Haupt, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2002
Localized unresectable neuroblastoma: results of treatment based on clinical prognostic factorsA Garaventa, L Boni, M S Lo Piccolo, et al.European Journal of Cancer (Oxford, England : 1990)|August 3, 2013
Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN studyJ A Kohler, H Rubie, V Castel, et al.Journal of Biological Regulators and Homeostatic Agents|April 23, 2014
Olea Europea-derived phenolic products attenuate antinociceptive morphine tolerance: an innovative strategic approach to treat cancer painC Muscoli, F Lauro, C Dagostino, et al.Annals of Hematology|April 26, 2015
Maternal and fetal outcomes in pregnant women with acute promyelocytic leukemiaMiguel A Sanz, Pau Montesinos, María F Casale, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1997
MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 childrenG P Tonini, L Boni, A Pession, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2001
Neuroblastoma with symptomatic spinal cord compression at diagnosis: treatment and results with 76 casesDe Bernardi B, C Pianca, P Pistamiglio, et al.Oecologia|June 30, 2018
Applying the principles of isotope analysis in plant and animal ecology to forensic science in the AmericasLesley A Chesson, Janet E Barnette, Gabriel J Bowen, et al.British Journal of Haematology|March 14, 2019
PET-adapted therapy after three cycles of ABVD for all stages of Hodgkin lymphoma: results of the GATLA LH-05 trialAstrid Pavlovsky, Isolda Fernandez, Nicolas Kurgansky, et al.NPJ Precision Oncology|November 28, 2018
Superhydrophobic lab-on-chip measures secretome protonation state and provides a personalized risk assessment of sporadic tumourN Malara, F Gentile, N Coppedè, et al.Pageof 8